Cutaneous T-Cell and B-Cell Lymphomas (CTCL and CBCL) are treated within the GW Cancer Center's Cutaneous Oncology Program and Cutaneous Lymphoma Clinic . CTCL and CBCL are irregular collections of immune cells (lymphocytes) in the superficial (epidermis) or deeper (dermis) skin layers.
- CTCL limited to the skin can be treated with a skin-directed therapy, while CTCL that also involves blood, lymph nodes, or other organs requires systematic therapy.
- CBCLs are less common than CTCL and the treatment of most primary CBCLs is different from the treatment of B cell lymphomas of the lymph nodes.
- Treatment of cutaneous lymphomas requires the coordination of dermatologists, dermatopathologists, and hematologic oncologists -- all are part of our multidisciplinary Cutaneous Lymphoma Clinic and work closely to care for each patient.
- The Cutaneous Lymphoma Clinic also treates very rare diseases of immune origin involving the skin, such as Natural Killer Cell Lymphomas (NK lymphomas), NK/T-cell lymphomas, Langerhans Cell Histiocytosis, and Leukemia Cutis.